UBS AM’s Sabra Healthcare REIT SBRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $30.5M | Buy |
1,561,933
+3,080
| +0.2% | +$61.1K | 0.01% | 784 |
|
|
2026
Q1 | $30M | Buy |
1,558,853
+53,476
| +4% | +$1.05M | 0.01% | 747 |
|
|
2025
Q4 | $28.5M | Buy |
+1,505,377
| New | +$27.9M | 0.01% | 741 |
|
|
2025
Q3 | – | Sell |
-333,532
| Closed | -$6.15M | – | 2549 |
|
|
2025
Q2 | $6.15M | Sell |
333,532
-1,354,445
| -80% | -$24M | ﹤0.01% | 1605 |
|
|
2025
Q1 | $29.5M | Buy |
1,687,977
+243,274
| +17% | +$4.1M | 0.01% | 812 |
|
|
2024
Q4 | $25M | Buy |
1,444,703
+40,127
| +3% | +$733K | 0.01% | 868 |
|
|
2024
Q3 | $26.1M | Buy |
1,404,576
+1,073,530
| +324% | +$18.1M | 0.01% | 853 |
|
|
2024
Q2 | $5.1M | Sell |
331,046
-683,955
| -67% | -$9.77M | ﹤0.01% | 1468 |
|
|
2024
Q1 | $15M | Sell |
1,015,001
-31,341
| -3% | -$434K | 0.01% | 881 |
|
|
2023
Q4 | $14.9M | Sell |
1,046,342
-34,824
| -3% | -$495K | 0.01% | 854 |
|
|
2023
Q3 | $15.1M | Sell |
1,081,166
-641
| -0.1% | -$8.2K | 0.01% | 828 |
|
|
2023
Q2 | $12.4M | Hold |
1,081,807
| – | – | 0.01% | 890 |
|
|
2023
Q1 | $12.4M | Buy |
1,081,807
+16,606
| +2% | +$205K | 0.01% | 890 |
|
|
2022
Q4 | $13.2M | Buy |
1,065,201
+74,521
| +8% | +$950K | 0.01% | 848 |
|
|
2022
Q3 | $13M | Sell |
990,680
-96,482
| -9% | -$1.43M | 0.01% | 876 |
|
|
2022
Q2 | $15.2M | Sell |
1,087,162
-73,424
| -6% | -$982K | 0.01% | 809 |
|
|
2022
Q1 | $17.3M | Buy |
1,160,586
+53,278
| +5% | +$729K | 0.01% | 878 |
|
|
2021
Q4 | $15M | Buy |
1,107,308
+130,525
| +13% | +$1.85M | 0.01% | 982 |
|
|
2021
Q3 | $14.4M | Buy |
976,783
+65,226
| +7% | +$1.1M | 0.01% | 958 |
|
|
2021
Q2 | $16.6M | Sell |
911,557
-40,749
| -4% | -$725K | 0.01% | 941 |
|
|
2021
Q1 | $16.5M | Sell |
952,306
-239,436
| -20% | -$4.21M | 0.01% | 913 |
|
|
2020
Q4 | $20.7M | Buy |
1,191,742
+167,291
| +16% | +$2.67M | 0.01% | 840 |
|
|
2020
Q3 | $14.1M | Buy |
1,024,451
+112,412
| +12% | +$1.65M | 0.01% | 859 |
|
|
2020
Q2 | $13.2M | Buy |
912,039
+120,483
| +15% | +$1.58M | 0.01% | 847 |
|
|
2020
Q1 | $8.64M | Buy |
791,556
+59,059
| +8% | +$1.09M | 0.01% | 899 |
|
|
2019
Q4 | $15.6M | Buy |
732,497
+54,818
| +8% | +$1.23M | 0.01% | 832 |
|
|
2019
Q3 | $15.6M | Buy |
677,679
+90,092
| +15% | +$1.92M | 0.01% | 822 |
|
|
2019
Q2 | $11.6M | Sell |
587,587
-32,169
| -5% | -$627K | 0.01% | 914 |
|
|
2019
Q1 | $12.1M | Buy |
619,756
+83,775
| +16% | +$1.59M | 0.01% | 880 |
|
|
2018
Q4 | $8.83M | Buy |
535,981
+2,452
| +0.5% | +$49.4K | 0.01% | 916 |
|
|
2018
Q3 | $12.3M | Buy |
533,529
+21,622
| +4% | +$490K | 0.01% | 879 |
|
|
2018
Q2 | $11.1M | Sell |
511,907
-1,250
| -0.2% | -$24.4K | 0.01% | 921 |
|
|
2018
Q1 | $9.06M | Buy |
513,157
+102,770
| +25% | +$1.81M | 0.01% | 953 |
|
|
2017
Q4 | $7.7M | Buy |
410,387
+61,031
| +17% | +$1.21M | 0.01% | 982 |
|
|
2017
Q3 | $7.66M | Buy |
349,356
+217,088
| +164% | +$4.9M | 0.01% | 963 |
|
|
2017
Q2 | $3.19M | Sell |
132,268
-1,257
| -0.9% | -$32K | ﹤0.01% | 1189 |
|
|
2017
Q1 | $3.73M | Buy |
133,525
+29,778
| +29% | +$781K | ﹤0.01% | 1106 |
|
|
2016
Q4 | $2.53M | Sell |
103,747
-9,380
| -8% | -$215K | ﹤0.01% | 1198 |
|
|
2016
Q3 | $2.85M | Buy |
113,127
+1,265
| +1% | +$30.3K | ﹤0.01% | 1235 |
|
|
2016
Q2 | $2.31M | Buy |
111,862
+16,166
| +17% | +$337K | ﹤0.01% | 1313 |
|
|
2016
Q1 | $1.92M | Sell |
95,696
-26,743
| -22% | -$513K | ﹤0.01% | 1383 |
|
|
2015
Q4 | $2.48M | Buy |
122,439
+11,133
| +10% | +$234K | ﹤0.01% | 1344 |
|
|
2015
Q3 | $2.58M | Buy |
111,306
+15,000
| +16% | +$383K | ﹤0.01% | 1309 |
|
|
2015
Q2 | $2.48M | Buy |
96,306
+12,712
| +15% | +$361K | ﹤0.01% | 1309 |
|
|
2015
Q1 | $2.77M | Buy |
83,594
+2,400
| +3% | +$77.9K | ﹤0.01% | 1228 |
|
|
2014
Q4 | $2.46M | Buy |
81,194
+23,988
| +42% | +$661K | ﹤0.01% | 1241 |
|
|
2014
Q3 | $1.39M | Sell |
57,206
-2,800
| -5% | -$77.6K | ﹤0.01% | 1436 |
|
|
2014
Q2 | $1.72M | Buy |
60,006
+12,300
| +26% | +$357K | ﹤0.01% | 1382 |
|
|
2014
Q1 | $1.33M | Buy |
47,706
+6,100
| +15% | +$168K | ﹤0.01% | 1466 |
|
|
2013
Q4 | $1.09M | Buy |
41,606
+2,300
| +6% | +$59.3K | ﹤0.01% | 1489 |
|
|
2013
Q3 | $904K | Sell |
39,306
-4,300
| -10% | -$106K | ﹤0.01% | 1547 |
|
|
2013
Q2 | $1.14M | Buy |
+43,606
| New | +$1.26M | ﹤0.01% | 1403 |
|
Other funds holding SBRA
CIM
UBS AM's SBRA Position: Q2 2026 in Review
UBS AM increased its Sabra Healthcare REIT (SBRA) stake by 0.2% in Q2 2026, buying an estimated $61.1K and bringing the position to 1,561,933 shares worth $30.5M. The position accounts for 0.01% of the portfolio, ranked #784.
UBS AM first reported a position in SBRA in Q2 2013 and has held it in 52 quarters since. 462 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.
- UBS AM held 1,561,933 shares of Sabra Healthcare REIT worth $30.5M as of Q2 2026.
- UBS AM bought 3,080 Sabra Healthcare REIT shares in Q2 2026, an estimated $61.1K.
- Sabra Healthcare REIT made up 0.01% of UBS AM's portfolio in Q2 2026, its #784 holding.
- UBS AM first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 52 quarters since.
- 462 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.